A Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MRX-I Tablets in Healthy Adult Subjects (Part 3)
Latest Information Update: 15 Feb 2017
At a glance
- Drugs Contezolid (Primary) ; Linezolid
- Indications Gram-positive infections; Methicillin-resistant Staphylococcus aureus infections; Vancomycin-resistant enterococcal infections
- Focus Adverse reactions
- 06 Feb 2017 Results from Part 1, 2 and 3, this and other two trials (see profile 239497 and 239499) published in the Antimicrobial Agents and Chemotherapy
- 25 Feb 2015 Results published in a MicuRx Pharmaceuticals media release.
- 25 Feb 2015 Status changed from not yet recruiting to completed, as reported in a MicuRx Pharmaceuticals media release.